Related Experiment Video
Updated: Aug 23, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Modulation of DNA/RNA Methylation by Small-Molecule Modulators and Their Implications in Cancer
Ayushi Verma1, Abhipsa Sinha1, Dipak Datta2
1Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow, India.
Abstract:
Chromatin is an organized complex of DNA, histone proteins, and RNA. Chromatin modifications include DNA methylation, RNA methylation, and histone acetylation and methylation. The methylation of chromatin complexes predominantly alters the regulation of gene expression, and its deregulation is associated with several human diseases including cancer. Cancer is a disease characterized by dynamic changes in the genetic and epigenetic architecture of a cell. Altered DNA methylation by DNA methyltransferases (DNMTs) and m6A RNA methylation facilitate tumor initiation and progression and thus serve as critical targets for cancer therapy. Small-molecule modulators of these epigenetic targets are at the hotspots of current cancer drug discovery research. Indeed, recent studies have led to the discovery of several chemical modulators against these targets, some of which have already gained approval for cancer therapy while others are undergoing clinical trials. In this chapter, we will focus on the role of small-molecule modulators in regulating DNA/RNA methylation and their implications in cancer.
Insights
Small molecules targeting DNA and RNA methylation are crucial for cancer therapy. These epigenetic modulators regulate gene expression, offering new avenues for cancer drug discovery and treatment.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Chromatin, a complex of DNA, histones, and RNA, undergoes modifications like DNA and RNA methylation.
- Deregulation of chromatin methylation is linked to human diseases, particularly cancer, due to altered gene expression.
- Cancer involves dynamic epigenetic changes, with DNA methyltransferases (DNMTs) and m6A RNA methylation playing key roles in tumor development.
Purpose of the Study:
- To review the role of small-molecule modulators in regulating DNA and RNA methylation.
- To discuss the implications of these modulators in cancer therapy and drug discovery.
Main Methods:
- Focus on small-molecule modulators targeting epigenetic mechanisms.
- Review of recent studies on chemical modulators of DNA/RNA methylation.
Main Results:
- Several small-molecule modulators targeting DNA/RNA methylation have been identified.
- Some modulators are approved for cancer therapy, while others are in clinical trials.
Conclusions:
- Small-molecule modulators offer promising therapeutic strategies for cancer by targeting epigenetic alterations.
- Targeting DNA/RNA methylation represents a significant area in current cancer drug discovery research.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
MicroRNAs
Regulation of Expression at Multiple Steps
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

